Catheter-Directed Thrombolysis Market
Catheter-Directed Thrombolysis is a New Therapy Treatment for Coronary Artery Patients to Give Efficient Results. FMI Analysis Key Trends
Catheter-Directed Thrombolysis Market By Delivery Mode, Indication, End User & Region - Forecast 2022-2032
Catheter-Directed Thrombolysis Market Outlook (2022-2032)
[324 Pages Report] The global catheter-directed thrombolysis market is valued at US$ 432.0 Million in 2022. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at US$ 814.0 Million by 2032.
The demand for catheter-directed thrombolysis is anticipated to increase as the treatment makes use of processes that remove the clot, be it based on thrombosis or embolization, the low time duration of treatment, and many other factors. This process is one of the most important preferred methods to treat stroke and related health issues.
|
Report Attribute |
Details |
|
Catheter-Directed Thrombolysis Market Value (2022) |
US$ 432.0 Million |
|
Catheter-Directed Thrombolysis Market Anticipated Value (2032) |
US$ 814.0 Million |
|
Catheter-Directed Thrombolysis Market Projected Growth Rate (2022-2032) |
5.9% |
Even if we compare the historic CAGR with the anticipated CAGR of the forecast period, there is a positive indication for the market. The historic CAGR of the catheter-directed thrombolysis market from 2016 to 2021 was 5.5%, while the anticipated CAGR is 5.9%. Though not much difference is observed, the good thing is that the market is progressing because of the number of benefits the catheter-directed thrombolytic therapy offers.
Let us know your requirement to get
100% FREE customization
Prominent Drivers and Restraints in the Catheter-Directed Thrombolysis Market
The seamlessness that this process offers is almost unmatchable. The entire process is done under the purview of x-ray imaging to get the correct site of the clot. Moreover, the technique is used for a number of treatments, which include thrombosis in the vascular bed, deep vein thrombosis, and thrombosis of dialysis fistulate. This is expected to increase the adoption of catheter-directed thrombolysis and makes the entire process an essential form of stroke medication.
Additionally, on comparing with the traditional heart surgery process, the process is extremely safe, and the duration for which the patient is admitted to the hospital is less. Besides that, based on the stats provided by WHO, it was found that around 17.9 million people died from heart disease in 2019, accounting for 32% of global deaths. This is something that has captured the attention of investors in the catheter-directed thrombolysis market, as these are mainly used for treating heart diseases.
Furthermore, the availability of emergency medical services and favorable health insurance coverage will also fuel the catheter-directed thrombolysis market. All these are anticipated to have a positive impact on the catheter-directed thrombolysis market trends and forecast. However, the application of an IV line in order to administer anesthesia might lead to certain injuries to the skin. This can be a cause of concern for the catheter-directed thrombolysis market.
Fluoroscopy: The “Big Cheese” of Catheter-Directed Thrombolysis Market
The amazing ability to keep a real time track of the movements inside the body part has been made possible because of fluoroscopy. The application of fluoroscopy has been perceived as life-saving surgical treatment. Apart from showing the real time view, this method also helps the medical practitioners to place the catheters inside the body with precision.
Moreover, fluoroscopy is used in a wide variety of examinations like Barium x-rays, placement of stents, orthopedic surgery to carry out variety of treatments which include viewing the gastrointestinal tract, visualizing blood vessels, to guide joint replacements etc. Thus, from the above, it can be clearly inferred that the usage of fluoroscopy is likely to increase the scope of catheter-directed thrombolysis market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCatheter-Directed Thrombolysis Market: Best Way Forward
|
Replacing X-rays with Ultrasounds |
Continuous exposure to x-rays can lead to health complications. Instead of this, the manufacturers can look for ways to replace x-rays with ultrasound, as these can be applied to any kind of patient, even pregnant women. Moreover, there are no side effects associated with the usage of ultrasounds, and the image quality provided by the usage of ultrasounds is also good. Thus, the replacement of x-rays with ultrasound might very well improve the catheter-directed thrombolysis market outlook. |
|
Replacing IV method with other methods |
Instead of applying an invasive technique to administer anesthesia, the administration can be done through other methods, like administering it in the form of a gas, topical liquid, or through any injection. The problem associated with intravenous medication is that it can lead to infection and damage the site of veins and may also lead to air embolism. However, replacing the IV line with anesthesia through gas, topical liquid, or an injection will avoid any instances of developing a skin infection or any other kind of complication as these are not pierced into the skin, thereby making the process fully non-invasive, except for the case of injection. The application of any one of these methods can be a positive step for the catheter-directed thrombolysis market. |
Regional Analysis
|
North America |
North America is expected to dominate the catheter-directed thrombolysis market share due to easy access to advanced healthcare facilities. According to Future Market Insights, the North American catheter-directed thrombolysis market has a market share of 53.4%, and is expected to grow at a rapid pace during the forecast period. Moreover, the region is meant for rapid technological advances. According to World Health Organization (WHO), approximately 900,000 people were diagnosed with pulmonary embolism and deep vein thrombosis in the U.S. in 2015. Among all end users, the hospital segment dominates the market for catheter-directed thrombolysis over the forecast period. The majority of cases of pulmonary embolism and deep vein thrombosis are treated in hospitals. |
|
Europe |
Europe is considered to be the 2nd largest market for catheter-directed thrombolysis owing to the presence of a robust reimbursement scenario and improved regulatory framework. According to Future Market Insights, the region has a market share of 24.1%, and is expected to grow significantly during the forecast period. Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis in the region is considered the standard form of treatment. Deep vein thrombosis (DVT) is the third most common cardiovascular pathology after coronary artery disease and stroke in the region. Due to the growing geriatric population and risk factors that include oral contraceptives, the demand for catheter-directed thrombolysis is expected to increase during the forecast period in Europe. |
A unified Market Research Subscription Platform, built for today's disparate research needs.
Start-up Ecosystem
Start-ups are developing new products with their unique ideas to solve several problems, especially in medical fields for patients. Start-ups in the catheter-directed thrombolysis market are making new devices which help to prevent cardiovascular disease. Some of the start-ups are:
Corveus Medical:
Corveus Medical is a US-based start-up company which has developed a new device to prevent heart failure in recent years. The innovative device developed by a company named “neuromodulation device” helps to access heart tissues uniquely and safely.
Moray Medical:
Moray Medical is another US-based start-up which improves leaky heart valves by providing microfluidic robotic methods. The start-up treats its patients safely with cost-effective therapies.
Competitive Landscape
The market is consolidated by the prominent vendors present all around the region in recent years. They are using several marketing tactics to acquire lion’s share and are anticipated to grow the catheter-directed thrombolysis market share during the forecast period.
Some of the marketing methodologies adopted by key players are partnerships, acquisitions, mergers, product launches, and collaborations among others. Global players such as Angio Dynamics, Inc. and Boston Scientific Corporation account for considerable market size. Several regional level players are also operating across key growth regions.
Recent Developments in the Catheter-Directed Thrombolysis Market:
- AngioDyamics Inc. is a prominent player when it comes to offering catheter-directed thrombolysis devices. Its Uni-FuseTM Infusion Catheter offers a highly effective treatment for clots. The catheter’s sturdier construction allows inserting stronger catheters with enhanced usability
- In September 2021, Boston Scientific Corporation purchased an 84% stake in Devoro Medical, further expanding its footprint in the blood clot removal platform of its existing thrombectomy portfolio. The deal saw Boston Scientific put down about US$ 269 Million upfront.
- ivascular SLU received the CE Mark approval for its BX covered stent iCover in May 2021. Balloon-expanding (BX) covered stents are commonly used for treating arteriosclerotic lesions in renal and iliac arteries, and for the treatment of aneurisms and ruptures. iCover can adapt to the most tortuous vessels due to its high flexibility and outstanding post-expansion capacity. It also offers excellent visibility.
Some of the key participants present in the market include
- AngioDynamics Inc.
- Boston Scientific Corporation
- iVascular SLU
- Straub Medical AG
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 5.9% from 2022 to 2032 |
|
Base Year for Estimation |
2022 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments
By Delivery Mode:
- Direct Delivery to Blood Clot Catheter-directed Thrombolysis
- Catheter-directed Thrombolysis by Positioning Medical Device at Clot Site
By Indication:
- Catheter-directed Thrombolysis for Pulmonary Embolism (PE)
- Catheter-directed Thrombolysis for Deep Vein Thrombosis (DVT)
- Catheter-directed Thrombolysis for Strokes
- Catheter-directed Thrombolysis for Other Indications
By End User:
- Hospitals
- Surgical Centers
- Radiology Clinics
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The catheter-directed thrombolysis market is predicted to advance at a CAGR of 5.9% from 2022-to 2032.
The catheter-directed thrombolysis market is valued at US$ 432 million as on 2022
The catheter-directed thrombolysis market is likely to hold a valuation of US$ 814.0 million by 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Delivery Mode
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Delivery Mode, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Delivery Mode, 2022-2032
5.3.1. Directly Delivery To Blood Clot
5.3.2. Positioning Medical Device At Clot Site
5.4. Y-o-Y Growth Trend Analysis By Delivery Mode, 2017-2021
5.5. Absolute $ Opportunity Analysis By Delivery Mode, 2022-2032
6. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032
6.3.1. Pulmonary Embolism (PE)
6.3.2. Deep Vein Thrombosis (DVT)
6.3.3. Stroke
6.3.4. Other
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032
7. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Center
7.3.3. Radiology Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Delivery Mode
9.2.3. By Indication
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Delivery Mode
9.3.3. By Indication
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Delivery Mode
10.2.3. By Indication
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Delivery Mode
10.3.3. By Indication
10.3.4. By End User
10.4. Key Takeaways
11. Europe Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Delivery Mode
11.2.3. By Indication
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Delivery Mode
11.3.3. By Indication
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. India
12.2.1.5. Malaysia
12.2.1.6. Singapore
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of APAC
12.2.2. By Delivery Mode
12.2.3. By Indication
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Delivery Mode
12.3.3. By Indication
12.3.4. By End User
12.4. Key Takeaways
13. MEA Catheter-Directed Thrombolysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Delivery Mode
13.2.3. By Indication
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Delivery Mode
13.3.3. By Indication
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Catheter-Directed Thrombolysis Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Delivery Mode
14.1.2.2. By Indication
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Delivery Mode
14.2.2.2. By Indication
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Delivery Mode
14.3.2.2. By Indication
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Delivery Mode
14.4.2.2. By Indication
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Delivery Mode
14.5.2.2. By Indication
14.5.2.3. By End User
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Delivery Mode
14.6.2.2. By Indication
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Delivery Mode
14.7.2.2. By Indication
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Delivery Mode
14.8.2.2. By Indication
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Delivery Mode
14.9.2.2. By Indication
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Delivery Mode
14.10.2.2. By Indication
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Delivery Mode
14.11.2.2. By Indication
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Delivery Mode
14.12.2.2. By Indication
14.12.2.3. By End User
14.13. Malaysia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Delivery Mode
14.13.2.2. By Indication
14.13.2.3. By End User
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Delivery Mode
14.14.2.2. By Indication
14.14.2.3. By End User
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Delivery Mode
14.15.2.2. By Indication
14.15.2.3. By End User
14.16. New Zealand
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Delivery Mode
14.16.2.2. By Indication
14.16.2.3. By End User
14.17. GCC Countries
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Delivery Mode
14.17.2.2. By Indication
14.17.2.3. By End User
14.18. South Africa
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Delivery Mode
14.18.2.2. By Indication
14.18.2.3. By End User
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Delivery Mode
14.19.2.2. By Indication
14.19.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Delivery Mode
15.3.3. By Indication
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Angio Dynamics, Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Boston Scientific Corporation
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. iVascular SLU
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Straub Medical AG
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Inari Medical, Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Medtronic Plc
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Penumbra, Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Straub Medical AG
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Teleflex Incorporated
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Thrombolex Inc.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032
Table 03: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 04: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 05: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 06: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032
Table 07: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 08: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 09: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032
Table 11: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 12: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032
Table 15: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 16: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 17: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032
Table 19: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 20: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 21: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Delivery Mode, 2017-2032
Table 23: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 24: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032
Figure 02: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032
Figure 03: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032
Figure 04: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) by Region, 2022-2032
Figure 05: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 06: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 07: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 08: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032
Figure 09: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032
Figure 10: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032
Figure 11: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 12: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 13: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 14: Global Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 15: Global Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 16: Global Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 17: Global Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032
Figure 18: Global Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032
Figure 19: Global Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032
Figure 20: Global Catheter-Directed Thrombolysis Market Attractiveness by Region, 2022-2032
Figure 21: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032
Figure 22: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032
Figure 23: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032
Figure 24: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032
Figure 29: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032
Figure 30: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032
Figure 31: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 32: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 33: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 34: North America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 35: North America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 36: North America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 37: North America Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032
Figure 38: North America Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032
Figure 39: North America Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032
Figure 40: North America Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032
Figure 42: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032
Figure 43: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032
Figure 44: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032
Figure 49: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032
Figure 50: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032
Figure 51: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 52: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 53: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 54: Latin America Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 55: Latin America Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 56: Latin America Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 57: Latin America Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032
Figure 58: Latin America Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032
Figure 59: Latin America Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032
Figure 60: Latin America Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032
Figure 61: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032
Figure 62: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032
Figure 63: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032
Figure 64: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032
Figure 69: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032
Figure 70: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032
Figure 71: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 72: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 73: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 74: Europe Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 75: Europe Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 76: Europe Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 77: Europe Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032
Figure 78: Europe Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032
Figure 79: Europe Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032
Figure 80: Europe Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032
Figure 81: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032
Figure 82: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032
Figure 83: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032
Figure 84: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032
Figure 85: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032
Figure 89: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032
Figure 90: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032
Figure 91: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 92: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 93: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 94: Asia Pacific Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 95: Asia Pacific Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 96: Asia Pacific Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 97: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032
Figure 98: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032
Figure 99: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032
Figure 100: Asia Pacific Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032
Figure 101: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by Delivery Mode, 2022-2032
Figure 102: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by Indication, 2022-2032
Figure 103: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by End User, 2022-2032
Figure 104: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) by Country, 2022-2032
Figure 105: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Delivery Mode, 2017-2032
Figure 109: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Delivery Mode, 2022-2032
Figure 110: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Delivery Mode, 2022-2032
Figure 111: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 112: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 113: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 114: MEA Catheter-Directed Thrombolysis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 115: MEA Catheter-Directed Thrombolysis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 116: MEA Catheter-Directed Thrombolysis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 117: MEA Catheter-Directed Thrombolysis Market Attractiveness by Delivery Mode, 2022-2032
Figure 118: MEA Catheter-Directed Thrombolysis Market Attractiveness by Indication, 2022-2032
Figure 119: MEA Catheter-Directed Thrombolysis Market Attractiveness by End User, 2022-2032
Figure 120: MEA Catheter-Directed Thrombolysis Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
